4,683 results match your criteria: "Fallopian Tube Disorders"
Unlabelled: Currently, chronic salpingo-oophoritis (CS) is still an urgent problem in the statistics of diseases of the female genital organs. In 35% of women, its course leads to disorder of the fallopian tubes patency and infertility. An additional indirect mechanism of infertility can be the morpho-functional failure of the endometrium.
View Article and Find Full Text PDFDiagnostics (Basel)
November 2024
Endocrinology Department, Elias Emergency University Hospital, 011461 Bucharest, Romania.
: Persistent Müllerian duct syndrome (PMDS) is a rare disorder of sex development (DSD) caused by mutations in the genes coding anti-Müllerian hormone (AMH) or the AMH receptor, characterized by the persistence of Müllerian derivatives, the uterus and/or fallopian tubes, in otherwise normally virilized boys. Testicular regression syndrome is common in PMDS, yet the association with supernumerary testis has been reported in only two patients where genetic testing was not performed. : Thus, we report an individual with this particular association caused by a previously unreported homozygous variant in the gene to enable future genotype-phenotype correlations in this rare disorder.
View Article and Find Full Text PDFStem Cell Rev Rep
December 2024
Department of Obstetrics and Gynecology, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Organoids are rapidly self-organizing 3D in vitro cultures derived from pluripotent stem cells (PSCs) or adult stem cells (ASCs) that possess disease-like characteristics with high success rates. Due to their ability to retain tissue structure, biological phenotypes, and genetic information, they have been utilized as a novel in vitro model for disease research. In recent years, scientists have established self-organizing 3D organoids for human endometrium, fallopian tubes, ovaries, and cervix by culturing stem cells with cytokines in 3D scaffolds.
View Article and Find Full Text PDFGynecol Minim Invasive Ther
September 2024
Medical Student of Department of Optometry, University of Houston, USA.
Objectives: This study aimed to determine the recurrence rate and related risk factors of primary fallopian tube cancer (PFTC).
Materials And Methods: We conducted a retrospective study of 47 patients with histopathological diagnosis of PFTC treated at Tu Du Hospital between January 1, 2015, and July 31, 2022. The cumulative recurrence rate was estimated using the life table method, and recurrence-associated factors were determined using the Log-rank test and Cox proportional hazard model.
Hell J Nucl Med
December 2024
Department of Nuclear Medicine, Qiantang Branch of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Gynecol Oncol
December 2024
Labcorp, Durham, NC, USA; Wake Forest Comprehensive Cancer Center and Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
BMC Womens Health
November 2024
Reproductive Medicine Research Center, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning, Guangxi, China.
Regen Ther
June 2024
Center of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
BMC Res Notes
November 2024
Department of Biology, Zand Institute of Higher Education, Shiraz, Iran.
Br J Cancer
November 2024
Department of Gynecology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
J Ovarian Res
November 2024
Department of Obstetrics and Gynecology, Peking University People's Hospital, No. 11 Xizhimen South Str., Xicheng District, Beijing, 100044, China.
BMC Cancer
November 2024
Center for Psychosocial Medicine, Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
J Ethnopharmacol
February 2025
Key Laboratory for Quality Evaluation of Bulk Herbs of Hunan Province, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China. Electronic address:
Diagnostics (Basel)
October 2024
Department of Obstetrics and Gynecology, University Medical Center of Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
BJC Rep
June 2024
Department of Pathology, Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA.
Pathol Int
December 2024
Department of Pathology, Imam Khomeini Hospital Complex, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
The study investigated the expression of GATA3, a transcription factor involved in immune regulation, in tubo-ovarian carcinomas and its association with clinicopathological factors and prognosis. Immunohistochemical analysis was performed on 91 tubo-ovarian carcinoma samples to determine the presence of GATA3-positive inflammatory cells in the tumor microenvironment. A threshold of 10% or higher was considered a positive expression.
View Article and Find Full Text PDFCase Rep Obstet Gynecol
October 2024
Department of Obstetrics and Gynecology, Faculty of Medicine, Kyorin University, Tokyo, Japan.
Front Oncol
October 2024
Department of Pathology, Guangyuan Central Hospital, Guangyuan, China.
Nutrients
September 2024
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Endeavor Health, Evanston, IL 60201, USA.
Cureus
September 2024
General Surgery, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, MEX.
Eur J Obstet Gynecol Reprod Biol
December 2024
Institute of Tropical Medicine and International Health, Charité - Universitätsmedizin Berlin, Germany. Electronic address:
Cancer Cell
November 2024
Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15213, USA; UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA; Tumor Microenvironment Center, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15232, USA; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA. Electronic address:
Gynecol Oncol
December 2024
Gynecologic Oncology Centre, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. Electronic address:
Background: The aim was to evaluate the performance of the Peritoneal Cancer Index (PCI) using imaging (ultrasound, contrast-enhanced computed tomography (CT), and whole-body diffusion-weighted magnetic resonance imaging (WB-DWI/MRI) in assessing peritoneal carcinomatosis and predicting non-resectability in tubo-ovarian carcinoma patients.
Methods: This was a prospective multicenter observational study. We considered all patients with suspected primary ovarian/tubal/peritoneal cancer who underwent preoperative ultrasound, CT, and WB-DWI/MRI (if available).